Cargando…
NSD3, a member of nuclear receptor‐binding SET domain family, is a potential prognostic biomarker for pancreatic cancer
BACKGROUND: Members of the nuclear receptor‐binding SET domain (NSD) family of histone H3 lysine 36 methyltransferases comprise NSD1, NSD2 (MMSET/WHSC1), and NSD3 (Wolf–Hirschhorn syndrome candidate 1‐like 1, WHSC1L1). While the expression of NSD genes is essential to normal biological processes and...
Autores principales: | Xiong, Qunli, Zhou, Ying, Zhang, Su, Zhang, Yaguang, Xu, Yongfeng, Yang, Yang, Zhou, Congya, Zeng, Zhu, Han, Junhong, Zhu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225198/ https://www.ncbi.nlm.nih.gov/pubmed/37062069 http://dx.doi.org/10.1002/cam4.5774 |
Ejemplares similares
-
Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic Cancer
por: Xiong, Qunli, et al.
Publicado: (2022) -
The dual role of p63 in cancer
por: Xu, Yongfeng, et al.
Publicado: (2023) -
Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Xu, Yongfeng, et al.
Publicado: (2022) -
Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3
por: Xiong, Qunli, et al.
Publicado: (2022) -
IV International Conference on Nuclear Structure and Dynamics (NSD2019)
por: de Angelis, G., et al.
Publicado: (2019)